Screener
Praxis Precision Medicines, Inc. PRAX Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCash.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
FAQ
- What is Praxis Precision Medicines, Inc.'s restricted cash?
- Praxis Precision Medicines, Inc. (PRAX) reported restricted cash of $0 in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s restricted cash changed year-over-year?
- Praxis Precision Medicines, Inc.'s restricted cash decreased by 100.0% year-over-year, from $416K to $0.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Praxis Precision Medicines, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude